Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Mirum Pharmaceuticals Inc (NASDAQ: MIRM)

 
MIRM Technical Analysis
5
As on 9th Jun 2023 MIRM STOCK Price closed @ 28.40 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 22.06 & Strong Buy for SHORT-TERM with Stoploss of 19.08 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MIRMSTOCK Price

Open 29.01 Change Price %
High 29.70 1 Day -0.65 -2.24
Low 28.09 1 Week 2.17 8.27
Close 28.40 1 Month 2.45 9.44
Volume 245500 1 Year 12.71 81.01
52 Week High 29.44 | 52 Week Low 15.50
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
MIRM
Daily Charts		 MIRM
Intraday Charts		 Whats New @
Bazaartrend		 MIRM
Free Analysis
 
MIRM Important Levels Intraday
RESISTANCE31.50
RESISTANCE30.51
RESISTANCE29.89
RESISTANCE29.28
SUPPORT27.52
SUPPORT26.91
SUPPORT26.29
SUPPORT25.30
 
MIRM Forecast April 2024
Share
4th UP Forecast45.18
3rd UP Forecast39.8
2nd UP Forecast36.47
1st UP Forecast33.15
1st DOWN Forecast23.65
2nd DOWN Forecast20.33
3rd DOWN Forecast17
4th DOWN Forecast11.62
 
MIRM Weekly Forecast
4th UP Forecast31.39
3rd UP Forecast30.43
2nd UP Forecast29.84
1st UP Forecast29.24
1st DOWN Forecast27.56
2nd DOWN Forecast26.96
3rd DOWN Forecast26.37
4th DOWN Forecast25.41
 
MIRM Forecast2024
4th UP Forecast59.08
3rd UP Forecast49.24
2nd UP Forecast43.16
1st UP Forecast37.08
1st DOWN Forecast19.72
2nd DOWN Forecast13.64
3rd DOWN Forecast7.56
4th DOWN Forecast-2.28
 
 
MIRM Other Details
Segment EQ
Market Capital 479403232.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MIRM Address
MIRM
 
MIRM Latest News
 
Your Comments and Response on Mirum Pharmaceuticals Inc
 
MIRM Business Profile
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate is Maralixibat, an investigational oral drug that is in Phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It is also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. The company was incorporated in 2018 and is headquartered in Foster City, California. Address: 950 Tower Lane, Foster City, CA, United States, 94404
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service